BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Sun Pharma and Philogen Sign Exclusive Agreement for NIDLEGY™ Commercialization in Europe, Australia, and New Zealand

Under the terms of the agreement, Sun Pharma will have exclusive rights to commercialise Nidlegy™ for indications of skin cancers in the territories ...

May 31, 2023 | News

AMP945 and FOLFIRINOX Synergize for Enhanced Pancreatic Cancer Treatment

Amplia's highly selective FAK inhibitor AMP945, when used in combination with FOLFIRINOX, enhances survival in a preclinical model of pancreatic ...

May 30, 2023 | News

FivepHusion partners with Treehill Partners and Syneos Health for strategic collaboration

FivepHusion, an advanced clinical-stage biotechnology company, today announced its collaboration with Treehill Partners, a New York-based strategic an...

May 29, 2023 | News

Avance Clinical Joins Global Heath Summit Campaign for Faster Access to Life-Changing and Life-Saving Therapies

Avance Clinical CEO, Yvonne Lungershausen, Chief Scientific Officer Gabriel Kremmidiotis, and Head of Scientific and Regulatory Affairs Jorgen Mould are in...

May 25, 2023 | News

Australia's First End-to-End mRNA CDMO Facility to Boost Vaccine Production and Research Capabilities

What is the significance of the first end-to-end mRNA process contract development and manufacturing organization (CDMO) establishment in Australia? ...

May 17, 2023 | News

BPAC and Novari Health Announce eReferral Integration

This bi-directional integration enables clinicians using the BPAC eReferral system to transmit referrals from within their practice management solution (PM...

May 16, 2023 | News

Telix to Provide Illuccix® to Bayer for Global Phase III Prostate Cancer Study, Including Japan

This global study is investigating the efficacy of Bayer's androgen receptor inhibitor (ARi) darolutamide plus androgen deprivation therapy (ADT) versus AD...

May 08, 2023 | News

Formus Labs Receives FDA Clearance for AI-Powered Orthopedic Surgery Planning Technology.

Formus Labs today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for Formus Hip as th...

May 04, 2023 | News

New Data Confirms Efficacy of ZIRCON Study in Imaging Kidney Cancer Masses Smaller Than 2cm at AUA

The results were featured in a late-breaking oral presentation delivered on Sunday, 30 April 2023 (CST) by Associate Professor Brian Shuch, ...

May 01, 2023 | News

Cartherics grants Shunxi Licence for CAR-T Cell Therapy for Ovarian Cancer in Greater China

CTH-004 has shown promising results in animal models of ovarian cancer and will be evaluated in a clinical trial under a research and development...

April 28, 2023 | News

Telix Accelerates Artificial Intelligence (AI) Development Program with Acquisition of Dedicaid

Dedicaid's core asset is a clinical decision support software (CDSS) AI platform capable of rapidly generating indication-specific CDSS applications from a...

April 27, 2023 | News

Bridgewest Perth Pharma to commercialize Sterile Injectable drugs under LumaCina business unit

The newly created business leverages the acclaimed team and production facility recently acquired by Bridgewest Group from Pfizer (Perth) Pty Ltd, a subsid...

April 26, 2023 | News

Cytiva supports BioCina with first GMP production and development facility for mRNA in Australia

Expanded facility to manufacture mRNA-based therapies and vaccines Researchers at the University of Adelaide will address the design and ma...

April 26, 2023 | News

Why Pharma and Medtech manufacturers are striving for digital maturity

Why pharma and medtech manufacturers are striving for...

April 25, 2023 | News

Stay Connected